Nasacort Spray May Become Available OTC

Wednesday, August 7th, 2013

A recently held federal advisory panel voted for triamcinolone acetodine (brand name Nasacort) to be made available over the counter in pharmacies. However, they added that the medicine should also be labeled clearly with the risk of slower growth in children and other conditions. Triamcinolone is currently considered a prescription medication. The United States FDA’s […]

Nasacort-related Medication Causing Side Effects in U.K’s Hay Fever Epidemic

Monday, July 8th, 2013

The United Kingdom is seeing a surge in hay fever cases, and patients suffering from this allergic condition have been warned by the NHS to avoid Kenalog. This drug was withdrawn when researchers found that it increased the risk of contagious diseases like measles and chicken pox for as much as three weeks. Kenalog jabs […]

New Nasacort-based Technique for Removing Cortical Adhesions

Tuesday, June 18th, 2013

Dr. Athanasios Nikolakopoulos recently spoke at the European Society of Ophthalmology about a novel technique to remove strongly resistant cortical vitreous adhesions with little trauma. The suggested technique involved hydro-lifting after initially removing as much vitreous as possible using triamcolone (brand name Nasacort). At present, the surgical procedures followed to remove resistant vitreous adherence are […]